A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

NCT07042100 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: Dose level (DL)1
BIOLOGICAL: DL2
BIOLOGICAL: DL3
BIOLOGICAL: DL4
BIOLOGICAL: DL5

Sponsor

Sun Pharma Advanced Research Company Limited